An employee demonstrates the production process of antiviral drug Favipiravir at the enterprise of ChemRar Group in Khimki, outside Moscow, Russia. Russia is set to test Favipiravir, an off-patent drug originally owned by Japanese drug maker Fujifilm Toyama Chemical, as a treatment for coronavirus patients as it holds potential against RNA viruses, one of which is Covid-19.
- Package: Russia Coronavirus Antiviral Drug
- Categories: Human Interest, Social Issues, Health
- Location: Khimki, Moscow region, Russia
- Event date: 30.04.2020
- Date published: 30.04.2020
- Author: Alexey Maishev
- Credit: Sputnik
- Source: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 5.8Mb
- Job-ID: f6ca9f882e838472